EZH1/2 Inhibition Augments the Anti-Tumor Effects of Sorafenib in Hepatocellular Carcinoma

0
34
Scientists investigated the relationship between the expression of EZH1/2 and the level of histone H3 Lysine 27 trimethylation in hepatocellular carcinoma.
[Scientific Reports]
Full Article